Jj. Meana et al., THE SUBTYPE-SELECTIVE ALPHA(2)-ADRENOCEPTOR ANTAGONISTS BRL-44408 ANDARC-239 ALSO RECOGNIZE 5-HT1A RECEPTORS IN THE RAT-BRAIN, European journal of pharmacology, 312(3), 1996, pp. 385-388
Several alpha(2)-adrenoceptor compounds have been reported to recogniz
e 5-HT1A receptors. The interaction of the alpha(2A/D)- and alpha(2B/C
)-adrenoceptor antagonists BRL 44408 (2-[2H-(1-methyl-1,3-dihydroisoin
dole) methyl]-4,5-dihydroimidazole) and ARC 239 (2-[2-[4-(o-methoxyphe
nyl)piperazin-1-yl] ethyl]-4,4-dimethyl-1,3-(2H,4H)-isoquinolinedione)
with 5-HT1A receptors was evaluated in rat brain. Competition experim
ents in cortex with both compounds against the specific binding of the
5-HT1A receptor radioligand [H-3]8-OH-DPAT (8-hydroxy-2-(n-dipropyl-a
mine)-tetralin) yielded K-i values in the nanomolar range, fairly clos
e to their previously reported affinities for alpha(2)-adrenoceptors.
Similar K-i values were obtained under alpha(2)-adrenoceptor masking c
onditions by competition assays of these compounds against the alpha(2
)-adrenoceptor and 5-HT1A receptor radioligand [H-3]RX 821002 (2-metho
xy idazoxan) specific binding in hippocampus. The results indicate tha
t BRL 44408 and ARC 239 recognize 5-HT1A receptors in addition to alph
a(2)-adrenoceptors. The fact should be considered when using these com
pounds to study alpha(2)-adrenoceptor subtypes.